company

NOR KLINIKKEN STADIONPARKEN AS

4020 STAVANGER

Return on Equity
131,41 %
Current Ratio
0,69
Debt-to-Equity Ratio
−0
Key figures (NOK)2022
Revenue8 020 000
Net Income−364 000
Total Assets704 000
Total Equity−277 000
Income (NOK)2022
Revenue8 020 000
Expenditure8 368 000
Operating Profit−349 000
Financial Income0
Financial Costs15 000
Financial Balance−15 000
Earnings Before Tax−364 000
Tax0
Net Income−364 000
Balance (NOK)2022
Total Fixed Assets23 000
Total Current Assets680 000
Total Assets704 000
Total Retained Equity−689 000
Total Equity−277 000
Total Long-Term Debt0
Total Current Debt980 000
Total Equity and Debt704 000
Cash flow (NOK)2022
Sales Income8 020 000
Other Income0
Revenue8 020 000
Cost of Goods Sold227 000
Salary Costs5 968 000
Depreciation92 000
Impairment0
Expenditure8 368 000
Operating Profit−349 000
Financial Income0
Financial Costs15 000
Financial Balance−15 000
Dividends0
Net Income−364 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures23 000
Total Tangible Assets23 000
Total Fiancial Fixed Assets0
Total Fixed Assets23 000
Stock43 000
Total Investments0
Cash, Bank346 000
Total Current Assets680 000
Total Assets704 000
Total Equity−277 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors377 000
Unpaid Taxes38 000
Dividends0
Other Current Debt564 000
Total Current Debt980 000
Total Equity and Debt704 000
Financial indicators2022
Return on Equity131,41 %
Debt-to-Equity Ratio−0
Operating Profit Margin−4,35 %
Current Ratio0,69
Quick Ratio0,73
Equity Ratio−0,39
Gross Profit Margin97,17 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English